國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Immunotherapy

Hajjar, Joud.

Immunotherapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Immunotherapyedited by Aung Naing, Joud Hajjar.
其他作者:	Naing, Aung.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	v, 184 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Immunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-53156-4
ISBN:	9783319531564$q(electronic bk.)

Immunotherapy
Immunotherapy (Naing)

Immunotherapy[electronic resource] /edited by Aung Naing, Joud Hajjar. - Cham :Springer International Publishing :2017. - v, 184 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,9950065-2598 ;. - Advances in experimental medicine and biology ;946..

1. Overview of Basic Immunology for Clinical Investigators -- 2. Interleukin-2. Old and New Approaches to Enhance Immune-Therapeutic Efficacy -- 3. Optimizing Radiotherapy with Immunotherapeutic Approaches -- 4. Harnessing the Immune System against Leukemia: Monoclonal antibodies and Checkpoint Strategies for AML -- 5. Immunotherapy in NSCLC: A Promising and Revolutionary Weapon -- 6. Immune Therapy for Sarcomas -- 7. Cancer Imaging in Immunotherapy -- 8. Adverse Events in Cancer Immunotherapy -- 9. Skin Reactions to Immune Checkpoint Inhibitors.

In the last decade, immunotherapy has revolutionized the practice of medicine in the field of oncology. This book, Immunotherapy, highlights the immunotherapeutic approaches currently in use and strategies to overcome the associated challenges. As comprehensive knowledge of basic immunology in the context of tumor biology is required to move further along the line of development in translational science, this book provides an overview of the cellular components of the immune system that interact with each other to provide a successful immune response. Immunotherapy offers promising antitumor activity across multiple cancer types as it does not attack the tumor but primarily revitalizes a suppressed immune system. It is beyond the scope of this book to discuss the immunotherapeutic approaches across the tumor board. However, the book features the role of immune-oncology in acute myeloid leukemia, non-small cell lung cancer, and sarcomas to showcase the recent advances in the management of cancer broadly classified as hematological malignancies, solid tumors, and tumors arising in the connective tissue. The book also discusses alternative formulations and combinatorial approaches to enhance the therapeutic index of these agents. As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. In this book, we discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies, and clinical implications. The book also outlines how recent advances in medical imaging technology have the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring. Importantly, the book attempts to increase the awareness to immune related adverse events and the need for aggressive and judicious management of toxicities to improve treatment outcomes in patients on immunotherapy In short, this book provides a broad understanding of immunotherapy and ways to leverage the immune system to make inroads in the fight against cancer.

ISBN: 9783319531564$q(electronic bk.)

Standard No.: 10.1007/978-3-319-53156-4doiSubjects--Topical Terms:

211033
Immunotherapy.

LC Class. No.: RM275

Dewey Class. No.: 616.079

Immunotherapy
LDR:03721nmm a2200325 a 4500 001 508796
003 DE-He213
005 20170404021226.0
006 m d
007 cr nn 008maaau
008 171121s2017 gw s 0 eng d
020 $a 9783319531564$q(electronic bk.)
020 $a 9783319531557$q(paper)
024 7 $a 10.1007/978-3-319-53156-4 $2 doi
035 $a 978-3-319-53156-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM275
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.079 $2 23
090 $a RM275 $b .I33 2017
130 0 $a Immunotherapy (Naing) $3 775189
245 1 0 $a Immunotherapy $h [electronic resource] / $c edited by Aung Naing, Joud Hajjar.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a v, 184 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v 995
505 0 $a 1. Overview of Basic Immunology for Clinical Investigators -- 2. Interleukin-2. Old and New Approaches to Enhance Immune-Therapeutic Efficacy -- 3. Optimizing Radiotherapy with Immunotherapeutic Approaches -- 4. Harnessing the Immune System against Leukemia: Monoclonal antibodies and Checkpoint Strategies for AML -- 5. Immunotherapy in NSCLC: A Promising and Revolutionary Weapon -- 6. Immune Therapy for Sarcomas -- 7. Cancer Imaging in Immunotherapy -- 8. Adverse Events in Cancer Immunotherapy -- 9. Skin Reactions to Immune Checkpoint Inhibitors.
520 $a In the last decade, immunotherapy has revolutionized the practice of medicine in the field of oncology. This book, Immunotherapy, highlights the immunotherapeutic approaches currently in use and strategies to overcome the associated challenges. As comprehensive knowledge of basic immunology in the context of tumor biology is required to move further along the line of development in translational science, this book provides an overview of the cellular components of the immune system that interact with each other to provide a successful immune response. Immunotherapy offers promising antitumor activity across multiple cancer types as it does not attack the tumor but primarily revitalizes a suppressed immune system. It is beyond the scope of this book to discuss the immunotherapeutic approaches across the tumor board. However, the book features the role of immune-oncology in acute myeloid leukemia, non-small cell lung cancer, and sarcomas to showcase the recent advances in the management of cancer broadly classified as hematological malignancies, solid tumors, and tumors arising in the connective tissue. The book also discusses alternative formulations and combinatorial approaches to enhance the therapeutic index of these agents. As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. In this book, we discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies, and clinical implications. The book also outlines how recent advances in medical imaging technology have the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring. Importantly, the book attempts to increase the awareness to immune related adverse events and the need for aggressive and judicious management of toxicities to improve treatment outcomes in patients on immunotherapy In short, this book provides a broad understanding of immunotherapy and ways to leverage the immune system to make inroads in the fight against cancer.
650 0 $a Immunotherapy. $3 211033
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
700 1 $a Naing, Aung. $3 775190
700 1 $a Hajjar, Joud. $3 775191
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-53156-4
950 $a Biomedical and Life Sciences (Springer-11642)